Newport Digital Technologies Inc. brings world-class technological expertise and creativity to the design and implementation of customized solutions for wireless broadband applications for customers. The company has competencies in five fast growing area of technology – RFID, WiMAX, LED signage, security and surveillance, and eLearning.

The management team at Newport Digital Technologies brings to the table a wealth of knowledge and experience from within the technology industry as well as the corporate world. They also have a strong track record of delivering results to both customers and investors. Here are the team members:

Mr. Richard Damion founded Newport Digital Technologies and is chairman of the company. He has over 40 years of experience developing, operating and ultimately selling numerous enterprises.

Mr. Gary DeMel is a 28-year veteran of the semiconductor and hi-tech industries. He has held several senior management positions within major technology

...

Newport Digital Technologies, Inc., a technology solutions driven company organized to focus on serving the fastest-emerging businesses in the technology space, announced today after the closing bell that it has implemented the licensing agreement with Microsoft Corp. to develop applications for its Windows Mobile platform. The Company has also progressed with their distribution agreement previously announced with Ingram Micro, Inc. (NYSE: IM), which will serve as its initial primary sales channel partner.

Newport Digital Technologies, Inc. (NPDT), in conjunction with leading Taiwan-based R&D technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), is commercializing a number of leading-edge Radio Frequency Identification (RFID) technologies. The first product is the N37B Ruggedized Handheld RFID reader and computing device that was unveiled this week at the Voluntary Interindustry Commerce Solutions Association (VICS) conference hosted by the University of Arkansas

...

The driving philosophy of corporate America used to be based on the principle of in-house development. If it wasn’t made in-house, companies simply weren’t interested. Companies wanted things over which they had full control, and from which they could enjoy 100% of the profits. Total independence. Total control. If a good idea came along that wasn’t developed in-house, the temptation was to find some way to tweak it and claim that it was developed in-house.

All of this led to some pretty nasty lawsuits. One of the best known cases, popularized in the movie Flash Of Genius, was that of Robert Kearns. Kearns was a Detroit engineer who developed the electronic intermittent windshield wiper for automobiles, getting his first patent for it in 1967. When he failed to get the major automakers to buy his idea and then saw them come

...

GlaxoSmithKline (GSK) recently received a positive recommendation from the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) for its cervical cancer vaccine, Cervarix. The CDC has recommended that Cervarix should be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic human papillomavirus (HPV) 16 and 18.   The committee also recommended that the vaccine should be used in 11 and 12 year old girls specifically and in girls and young women who have not yet been vaccinated. Cervarix, which received approval in the U.S. recently, is indicated for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic HPV types 16 and 18 for use in girls and young women (aged 10-25).   The ACIP’s recommendation should help increase adoption of the vaccine, which is slated to hit the U.S. market later this ...

Yesterday, Amgen Inc (AMGN) announced that the US Food and Drug Administration (FDA) delayed the approval of its osteoporosis drug denosumab, with a proposed trade name of Prolia.  In response to the Biologic License Applications (BLA) filed by Amgen in Feb 2009 for Prolia, the Complete Response Letter (CRL) issued by the FDA requested several items, including further information on the design of Amgen's previously submitted post-marketing surveillance program. The FDA has asked the company to develop a strategy to evaluate the risks of Prolia. However, the agency did not ask for further clinical trials, which would have resulted in a longer delay.  Management believes that it can satisfy the queries of the FDA. The company intends to market Prolia for the treatment and prevention of postmenopausal osteoporosis (PMO) and bone loss in patients undergoing hormone ablation for either prostate or breast cancer.  Based on ...

Micro Imaging Technology, Inc. announced today that Biotek Sdn Bhd has purchased its first MIT 1000 System. Biotek Sdn Bhd was recently signed as the company’s distributor for Malaysia and other Association of Southeast Asian Nations (ASEAN) which includes Indonesia, Singapore, The Philippines, Thailand and Cambodia, in addition to others.

Recognized as a premier distributor in the food protection market, Biotek distributes products that are complementary to the MIT 1000 Rapid Microbial Identification System. “Our sales strategy is to demonstrate the features and benefits of this System in typical applications, enabling prospective clients to immediately understand its value. We have found this approach produces much faster sales than other traditional methods,” commented Biotek’s Director, W.C. Fong. “We are pleased to add the MIT 1000 System to our product portfolio. Its rapid test time coupled with its low operating cost will be attractive to many of our customers.”

Biotek has been scheduled

...

GlaxoSmithKline (GSK) received good news last week with the receipt of approval from the US Food and Drug Administration (FDA) for its cervical cancer vaccine, Cervarix. The vaccine received approval for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25). Last month, an advisory committee of the FDA had voted 12-1 in favor of the efficacy of the vaccine and 11-1 in support of its safety. Cervarix also received approval in Japan for girls aged 10 and above, becoming the first cervical vaccine to gain approval in Japan. The American Cancer Society estimates that about 11,000 women will be diagnosed with cervical cancer and 4,000 women will die from the disease in 2009 in the US. Globally, more than 500,000 women are expected to be diagnosed with cervical ...

For Immediate Release

Chicago, IL – October 19, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Qualcomm Inc. (QCOM), MetroPCS Communications Inc. (PCS), NTT DoCoMo (DCM), Nokia Corp. (NOK) and Motorola Inc. (MOT).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s AnalystBlog:

Qualcomm Wins M-Banking Deal

Qualcomm Inc. (QCOM) recently entered into an agreement with MetroPCS Communications Inc. (PCS), through which the latter will offer mobile banking services to its customers using Qualcomm’s mobile banking applications. Qualcomm provides mobile banking solutions through its subsidiary Firethorn Holding LLC.

...

Newport Digital Technologies, Inc. offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900

...

For Immediate Release

Chicago, IL – October 14, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: American International Group (AIG), Morgan Stanley (MS), Elan Corporation (ELN), Biogen Idec (BIIB) and Johnson & Johnson (JNJ).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Tuesday’s Analyst Blog:

AIG to Sell Taiwan Life Unit

American International Group (AIG) said on Monday that it has decided to sell its stake of almost 98% in Taiwan life insurance unit Nan Shan Life Insurance Co. for about $2.2 billion to a group led by Hong Kong-based

...